Novavax, Inc.
NVAX
Market Cap$1.21B
Close$
$24.78
213.7% upside
Current Fair Value
213.7% upsideUndervalued by 213.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.21 Billion |
|---|---|
| Enterprise Value | $1.29 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.23 |
| Beta | 2.5 |
| Outstanding Shares | 162,019,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.86 |
|---|---|
| PEG | -8.32 |
| Price to Sales | 1.32 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.2 |
| Enterprise Value to EBIT | 3.01 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 9.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck